Theranos Says Investors Can't Sue Over Blood Tests

By Dorothy Atkins · March 1, 2017, 9:14 PM EST

Beleaguered blood-testing startup Theranos and its executives urged a California federal judge Wednesday to toss a putative securities class action alleging they misled investors about the accuracy of Theranos' tests, saying...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Case Information

Case Title

Colman et al v. Theranos, Inc. et al

Case Number

5:16-cv-06822

Court

California Northern

Nature of Suit

Other Fraud

Date Filed

November 28, 2016